{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:53Z","timestamp":1791415973329,"version":"4.3.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Conacyt DAAD"},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00253-015-7267-9","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T22:59:52Z","timestamp":1452725992000},"page":"2121-2132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production"],"prefix":"10.1007","volume":"100","author":[{"given":"Felipe","family":"Tapia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"V\u00e1zquez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"7267_CR1","volume-title":"Viral vaccine production in cell culture encyclopedia of cell technology","author":"JG Aunins","year":"2003","unstructured":"Aunins JG (2003) Viral vaccine production in cell culture encyclopedia of cell technology. John Wiley Sons, Inc"},{"issue":"1","key":"7267_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/btpr.539","volume":"27","author":"A Bock","year":"2011","unstructured":"Bock A, Schulze-Horsel J, Schwarzer J, Rapp E, Genzel Y, Reichl U (2011) High-density microcarrier cell cultures for influenza virus production. Biotechnol Prog 27(1):241\u2013250. doi: 10.1002\/btpr.539","journal-title":"Biotechnol Prog"},{"key":"7267_CR3","doi-asserted-by":"crossref","DOI":"10.4324\/9780203895160","volume-title":"Animal cell technology: from biopharmaceuticals to gene therapy","author":"L Castilho","year":"2008","unstructured":"Castilho L, Moraes A, Augusto E, Butler M (2008) Animal cell technology: from biopharmaceuticals to gene therapy. Taylor & Francis Group, New York; Abingdon England"},{"issue":"3","key":"7267_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/btpr.1704","volume":"29","author":"M-F Clincke","year":"2013","unstructured":"Clincke M-F, Molleryd C, Zhang Y, Lindskog E, Walsh K, Chotteau V (2013) Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor. Part I Effect of the Cell density on the Process. Biotechnol Prog 29(3):754\u2013767. doi: 10.1002\/btpr.1704","journal-title":"Biotechnol Prog"},{"issue":"3","key":"7267_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1021\/bp034237l","volume":"20","author":"V Cortin","year":"2004","unstructured":"Cortin V, Thibault J, Jacob D, Garnier A (2004) High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog 20(3):858\u2013863. doi: 10.1021\/bp034237l","journal-title":"Biotechnol Prog"},{"issue":"5","key":"7267_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF00263855","volume":"30","author":"CD Gooijer De","year":"1989","unstructured":"De Gooijer CD, Van Lier FLJ, Van den End EJ, Vlak JM, Tramper J (1989) A model for baculovirus production with continuous insect cell-cultures. Appl Microbiol Biotechnol 30(5):497\u2013501. doi: 10.1007\/BF00263855","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"7267_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/bit.260400413","volume":"40","author":"CD Gooijer De","year":"1992","unstructured":"De Gooijer CD, Koken RH, Van Lier FL, Kool M, Vlak JM, Tramper J (1992) A structured dynamic model for the baculovirus infection process in insect-cell reactor configurations. Biotechnol Bioeng 40(4):537\u2013548. doi: 10.1002\/bit.260400413","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"7267_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/bit.260400105","volume":"40","author":"D Broise de la","year":"1992","unstructured":"de la Broise D, Noiseux M, Massie B, Lemieux R (1992) Hybridoma perfusion systems: a comparison study. Biotechnol Bioeng 40(1):25\u201332. doi: 10.1002\/bit.260400105","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"7267_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/JVI.23.1.126-132.1977","volume":"23","author":"JM Demarchi","year":"1977","unstructured":"Demarchi JM, Kaplan AS (1977) Physiological state of human embryonic lung-cells affects their response to human cytomegalovirus. J Virol 23(1):126\u2013132","journal-title":"J Virol"},{"issue":"1","key":"7267_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1026192228471","volume":"42","author":"JE Dowd","year":"2003","unstructured":"Dowd JE, Jubb A, Kwok KE, Piret JM (2003) Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates. Cytotechnology 42(1):35\u201345. doi: 10.1023\/A:1026192228471","journal-title":"Cytotechnology"},{"issue":"3","key":"7267_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jctb.5020220310","volume":"22","author":"Z Fencl","year":"1972","unstructured":"Fencl Z, \u0158i\u010dica J, Kode\u0161ov\u00e1 J (1972) The use of the multi-stage chemostat for microbial product formation. J Appl Chem Biotechnol 22(3):405\u2013416","journal-title":"J Appl Chem Biotechnol"},{"issue":"5","key":"7267_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/biot.201400429","volume":"10","author":"T Frensing","year":"2015","unstructured":"Frensing T (2015) Defective interfering viruses and their impact on vaccines and viral vectors. Biotechnology J 10(5):681\u2013689. doi: 10.1002\/biot.201400429","journal-title":"Biotechnology J"},{"issue":"9","key":"7267_CR13","doi-asserted-by":"publisher","first-page":"e72288","DOI":"10.1371\/journal.pone.0072288","volume":"8","author":"T Frensing","year":"2013","unstructured":"Frensing T, Heldt FS, Pflugmacher A, Behrendt I, Jordan I, Flockerzi D, Genzel Y, Reichl U (2013) Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One 8(9):e72288. doi: 10.1371\/journal.pone.0072288","journal-title":"PLoS One"},{"key":"7267_CR14","doi-asserted-by":"publisher","unstructured":"Gallo-Ramirez LE, Nikolay A, Genzel Y, Reichl U (2015) Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev Vaccines 1:\u201315. doi: 10.1586\/14760584.2015.1067144","DOI":"10.1586\/14760584.2015.1067144"},{"issue":"1","key":"7267_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jbiotec.2011.11.007","volume":"157","author":"J G\u00e1lvez","year":"2012","unstructured":"G\u00e1lvez J, Lecina M, Sol\u00e0 C, Cair\u00f3 JJ, G\u00f2dia F (2012) Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements. J Biotechnol 157(1):214\u2013222. doi: 10.1016\/j.jbiotec.2011.11.007","journal-title":"J Biotechnol"},{"issue":"24","key":"7267_CR16","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","volume":"32","author":"Y Genzel","year":"2014","unstructured":"Genzel Y, Vogel T, Buck J, Behrendt I, Ramirez DV, Schiedner G, Jordan I, Reichl U (2014) High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine 32(24):2770\u20132781. doi: 10.1016\/j.vaccine.2014.02.016","journal-title":"Vaccine"},{"issue":"4","key":"7267_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bit.20947","volume":"95","author":"K Ghani","year":"2006","unstructured":"Ghani K, Garnier A, Coelho H, Transfiguracion J, Trudel P, Kamen A (2006) Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnol Bioeng 95(4):653\u2013660. doi: 10.1002\/bit.20947","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"7267_CR18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AEM.13.6.909-917.1965","volume":"13","author":"GB Gori","year":"1965","unstructured":"Gori GB (1965) Continuous cultivation of virus in cell suspensions by use of the lysostat. Appl Microbiol 13(6):909\u2013917","journal-title":"Appl Microbiol"},{"issue":"1\u20133","key":"7267_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF02521726","volume":"9","author":"JB Griffiths","year":"1992","unstructured":"Griffiths JB, Looby D, Racher AJ (1992) Maximization of perfusion systems and process comparison with batch-type cultures\u2014maximization of perfusion cultures. Cytotechnology 9(1\u20133):3\u20139. doi: 10.1007\/Bf02521726","journal-title":"Cytotechnology"},{"issue":"7","key":"7267_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/bit.20074","volume":"86","author":"O Henry","year":"2004","unstructured":"Henry O, Dormond E, Perrier M, Kamen A (2004) Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng 86(7):765\u2013774. doi: 10.1002\/Bit.20074","journal-title":"Biotechnol Bioeng"},{"issue":"5\u20136","key":"7267_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ymben.2005.08.002","volume":"7","author":"O Henry","year":"2005","unstructured":"Henry O, Perrier M, Kamen A (2005) Metabolic flux analysis of HEK-293 cells in perfusion cultures for the production of adenoviral vectors. Metab Eng 7(5\u20136):467\u2013476. doi: 10.1016\/j.ymben.2005.08.002","journal-title":"Metab Eng"},{"issue":"Pt 10","key":"7267_CR22","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1099\/mic.0.27924-0","volume":"151","author":"PA Hoskisson","year":"2005","unstructured":"Hoskisson PA, Hobbs G (2005) Continuous culture\u2014making a comeback? Microbiology 151(Pt 10):3153\u20133159. doi: 10.1099\/mic.0.27924-0","journal-title":"Microbiology"},{"key":"7267_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-59745-457-5_22","volume":"388","author":"YC Hu","year":"2007","unstructured":"Hu YC, Bentley WE (2007) Alternative bioreactor strategy for probing infection and production. Methods Mol Biol 388:419\u2013426. doi: 10.1007\/978-1-59745-457-5_22","journal-title":"Methods Mol Biol"},{"issue":"2","key":"7267_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1023\/A:1007970020274","volume":"24","author":"YC Hu","year":"1997","unstructured":"Hu YC, Wang MY, Bentley WE (1997) A tubular segmented-flow bioreactor for the infection of insect cells with recombinant baculovirus. Cytotechnology 24(2):143\u2013152. doi: 10.1023\/A:1007970020274","journal-title":"Cytotechnology"},{"issue":"6","key":"7267_CR25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AEM.14.6.940-952.1966","volume":"14","author":"H Jacobson","year":"1966","unstructured":"Jacobson H, Jacobson LS (1966) Virustat, a device for continuous production of viruses. Appl Microbiol 14(6):940\u2013952","journal-title":"Appl Microbiol"},{"issue":"1","key":"7267_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/v5010321","volume":"5","author":"I Jordan","year":"2013","unstructured":"Jordan I, Horn D, John K, Sandig V (2013) A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium. Viruses 5(1):321\u2013339. doi: 10.3390\/v5010321","journal-title":"Viruses"},{"issue":"1","key":"7267_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/0022-1317-9-1-1","volume":"9","author":"DG Kilburn","year":"1970","unstructured":"Kilburn DG, van Wezel AL (1970) The effect of growth rate in continuous-flow cultures on the replication of rubella virus in BHK cells. J Gen Virol 9(1):1\u20137","journal-title":"J Gen Virol"},{"key":"7267_CR28","volume-title":"Cell culture technology for pharmaceutical and cell-based therapies","author":"DS Kompala","year":"2006","unstructured":"Kompala DS, Ozturk SS (2006) Optimization of high cell density perfusion bioreactors. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies. Taylor & Francis, New York"},{"issue":"12","key":"7267_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF01026994","volume":"10","author":"R Kompier","year":"1988","unstructured":"Kompier R, Tramper J, Vlak J (1988) A continuous process for the production of baculovirus using insect-cell cultures. Biotechnol Lett 10(12):849\u2013854","journal-title":"Biotechnol Lett"},{"issue":"3","key":"7267_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jps.24268","volume":"104","author":"KB Konstantinov","year":"2015","unstructured":"Konstantinov KB, Cooney CL (2015) White paper on continuous bioprocessing. May 20\u201321, 2014 Continuous manufacturing symposium. J Pharm Sci 104(3):813\u2013820. doi: 10.1002\/jps.24268","journal-title":"J Pharm Sci"},{"issue":"2","key":"7267_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0042-6822(91)91003-Y","volume":"183","author":"M Kool","year":"1991","unstructured":"Kool M, Voncken JW, van Lier FL, Tramper J, Vlak JM (1991) Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties. Virology 183(2):739\u2013746","journal-title":"Virology"},{"issue":"1\u20133","key":"7267_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00350393","volume":"20","author":"PJ Krell","year":"1996","unstructured":"Krell PJ (1996) Passage effect of virus infection in insect cells. Cytotechnology 20(1\u20133):125\u2013137. doi: 10.1007\/BF00350393","journal-title":"Cytotechnology"},{"key":"7267_CR33","volume-title":"Chemical reaction engineering","author":"O Levenspiel","year":"1972","unstructured":"Levenspiel O (1972) Chemical reaction engineering, 2d edn. Wiley, New York","edition":"2d"},{"issue":"1","key":"7267_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.1990.tb18159.x","volume":"613","author":"FLJ Lier","year":"1990","unstructured":"Lier FLJ, Kool M, End EJ, Gooijer CD, Usmany M, Vlak JM, Tramper J (1990) Production of baculovirus or recombinant derivatives in continuous insect-cell bioreactors. Annals N Y Acad Sci 613(1):183\u2013190","journal-title":"Annals N Y Acad Sci"},{"issue":"6","key":"7267_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/bit.260390605","volume":"39","author":"DA Lindsay","year":"1992","unstructured":"Lindsay DA, Betenbaugh MJ (1992) Quantification of cell-culture factors affecting recombinant protein yields in baculovirus-infected insect cells. Biotechnol Bioeng 39(6):614\u2013618. doi: 10.1002\/bit.260390605","journal-title":"Biotechnol Bioeng"},{"issue":"36","key":"7267_CR36","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.vaccine.2009.05.083","volume":"27","author":"V Lohr","year":"2009","unstructured":"Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U (2009) New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine 27(36):4975\u20134982. doi: 10.1016\/j.vaccine.2009.05.083","journal-title":"Vaccine"},{"key":"7267_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1472-6750-14-72","volume":"14","author":"V Lohr","year":"2014","unstructured":"Lohr V, Hadicke O, Genzel Y, Jordan I, Buntemeyer H, Klamt S, Reichl U (2014) The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. Bmc Biotechnol 14:72. doi: 10.1186\/1472-6750-14-72","journal-title":"Bmc Biotechnol"},{"key":"7267_CR38","unstructured":"M\u00e1lek I, Fencl Z (1966) Theoretical and methodological basis of continuous culture of microorganisms (trans: Liebster J). Pub. House of the Czechoslovak Academy of Sciences; Academic Press, Prague and New York"},{"issue":"2","key":"7267_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/bit.10773","volume":"84","author":"L Maranga","year":"2003","unstructured":"Maranga L, Brazao TF, Carrondo MJT (2003) Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84(2):245\u2013253. doi: 10.1002\/bit.10773","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"7267_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/bit.25459","volume":"112","author":"SM Mercier","year":"2014","unstructured":"Mercier SM, Diepenbroek B, Martens D, Wijffels RH, Streefland M (2014) Characterization of apoptosis in PER.C6 batch and perfusion cultures. Biotechnol Bioeng 112(3):569\u2013578. doi: 10.1002\/bit.25459","journal-title":"Biotechnol Bioeng"},{"key":"7267_CR41","doi-asserted-by":"publisher","unstructured":"Nadeau I, Kamen A (2003) Production of adenovirus vector for gene therapy. Biotechnol Adv 20(7-8):475\u2013489. doi 10.1016\/S0734-9750(02)00030-7","DOI":"10.1016\/S0734-9750(02)00030-7"},{"issue":"11","key":"7267_CR42","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.cherd.2013.04.002","volume":"91","author":"AW Nienow","year":"2013","unstructured":"Nienow AW, Scott WH, Hewitt CJ, Thomas CR, Lewis G, Amanullah A, Kiss R, Meier SJ (2013) Scale-down studies for assessing the impact of different stress parameters on growth and product quality during animal cell culture. Chem Eng Res Des 91(11):2265\u20132274. doi: 10.1016\/j.cherd.2013.04.002","journal-title":"Chem Eng Res Des"},{"issue":"2920","key":"7267_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.112.2920.715","volume":"112","author":"A Novick","year":"1950","unstructured":"Novick A, Szilard L (1950) Description of the chemostat. Science 112(2920):715\u2013716. doi: 10.1126\/science.112.2920.715","journal-title":"Science"},{"key":"7267_CR44","doi-asserted-by":"crossref","unstructured":"Ozturk SS (1994) Optimization and scale-up of high density cell culture bioreactors. In: Galindo E, Ramirez OT (eds) Adv bioprocess Eng. Springer edn, Dordrecht, pp. 133\u2013139","DOI":"10.1007\/978-94-017-0641-4_19"},{"issue":"1\u20133","key":"7267_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00353919","volume":"22","author":"SS Ozturk","year":"1996","unstructured":"Ozturk SS (1996) Engineering challenges in high density cell culture systems. Cytotechnology 22(1\u20133):3\u201316. doi: 10.1007\/BF00353919","journal-title":"Cytotechnology"},{"key":"7267_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1472-6750-11-84","volume":"11","author":"E Petiot","year":"2011","unstructured":"Petiot E, Jacob D, Lanthier S, Lohr V, Ansorge S, Kamen AA (2011) Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol 11:84. doi: 10.1186\/1472-6750-11-84","journal-title":"BMC Biotechnol"},{"issue":"6","key":"7267_CR47","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/bit.20178","volume":"87","author":"GP Pijlman","year":"2004","unstructured":"Pijlman GP, de Vrij J, van den End FJ, Vlak JM, Martens DE (2004) Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors. Biotechnol Bioeng 87(6):743\u2013753. doi: 10.1002\/bit.20178","journal-title":"Biotechnol Bioeng"},{"issue":"12","key":"7267_CR48","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.vaccine.2008.01.032","volume":"26","author":"M Pohlscheidt","year":"2008","unstructured":"Pohlscheidt M, Langer U, Minuth T, Bodeker B, Apeler H, Horlein HD, Paulsen D, Rubsamen-Waigmann H, Henzler HJ, Reichl U (2008) Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium. Vaccine 26(12):1552\u20131565. doi: 10.1016\/j.vaccine.2008.01.032","journal-title":"Vaccine"},{"issue":"1","key":"7267_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.24608","volume":"110","author":"J Pollock","year":"2013","unstructured":"Pollock J, Ho SV, Farid SS (2013) Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty. Biotechnol Bioeng 110(1):206\u2013219. doi: 10.1002\/bit.24608","journal-title":"Biotechnol Bioeng"},{"key":"7267_CR50","first-page":"123","volume":"107","author":"F Roth","year":"1994","unstructured":"Roth F, Ullrich MW, Elizondo Herrera A, Seifert HSH (1994) Kontinuierliche Producktion von MKS-Virus in einem zweistufigen Bioreaktorsystem. Berl M\u00fcnch Tier\u00e4rztl Wschr 107:123\u2013127","journal-title":"Berl M\u00fcnch Tier\u00e4rztl Wschr"},{"issue":"2","key":"7267_CR51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.24.2.539-544.1979","volume":"24","author":"LF Roumillat","year":"1979","unstructured":"Roumillat LF, Feorino PM, Lukert PD (1979) Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1. Infect Immun 24(2):539\u2013544","journal-title":"Infect Immun"},{"issue":"2","key":"7267_CR52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/iai.29.2.671-677.1980","volume":"29","author":"LF Roumillat","year":"1980","unstructured":"Roumillat LF, Feorino PM, Caplan DD, Lukert PD (1980) Analysis and characterization of herpes simplex virus after its persistence in a lymphoblastoid cell line for 15\u00a0months. Infect Immun 29(2):671\u2013677","journal-title":"Infect Immun"},{"issue":"19","key":"7267_CR53","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","volume":"25","author":"S Rourou","year":"2007","unstructured":"Rourou S, van der Ark A, van der Velden T, Kallel H (2007) A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25(19):3879\u20133989. doi: 10.1016\/j.vaccine.2007.01.086","journal-title":"Vaccine"},{"key":"7267_CR54","unstructured":"Roya S, Mehrad MF (2008) The applicable approach to increase the animal viral vaccine production by rolling method in Iran. 15th Congress of the Federation of Asian Veterinary Associations, Fava-Oie Joint Symposium on Emerging Diseases, Proceedings:115\u2013117"},{"issue":"5","key":"7267_CR55","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.vaccine.2012.10.070","volume":"31","author":"BP Sanders","year":"2013","unstructured":"Sanders BP, Edo-Matas D, Custers JHHV, Koldijk MH, Klaren V, Turk M, Luitjens A, Bakker WAM, Uytdehaag F, Goudsmit J, Lewis JA, Schuitemaker H (2013) PER.C6 (R) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine. Vaccine 31(5):850\u2013856. doi: 10.1016\/j.vaccine.2012.10.070","journal-title":"Vaccine"},{"issue":"3","key":"7267_CR56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/jctb.4335","volume":"90","author":"S Sarkar","year":"2015","unstructured":"Sarkar S, Chowdhury R, Mukherjee A (2015) Mathematical modelling of ideal and non-ideal continuous stirred tank bioreactor using simulated solution. J Chem Technol Biot 90(3):484\u2013491. doi: 10.1002\/jctb.4335","journal-title":"J Chem Technol Biot"},{"issue":"1\u20133","key":"7267_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00353938","volume":"22","author":"BQ Shen","year":"1996","unstructured":"Shen BQ, Clarke MF, Palsson BO (1996) Kinetics of retroviral production from the amphotropic PsiCRIP murine producer cell line. Cytotechnology 22(1\u20133):185\u2013195. doi: 10.1007\/BF00353938","journal-title":"Cytotechnology"},{"issue":"3","key":"7267_CR58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00253-012-4375-7","volume":"97","author":"B Sun","year":"2013","unstructured":"Sun B, Yu X, Kong W, Sun S, Yang P, Zhu C, Zhang H, Wu Y, Chen Y, Shi Y, Zhang X, Jiang C (2013) Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor. Appl Microbiol Biotechnol 97(3):1063\u20131070. doi: 10.1007\/s00253-012-4375-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"7267_CR59","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.vaccine.2013.11.044","volume":"32","author":"F Tapia","year":"2014","unstructured":"Tapia F, Vogel T, Genzel Y, Behrendt I, Hirschel M, Gangemi JD, Reichl U (2014) Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 32(8):1003\u20131011. doi: 10.1016\/j.vaccine.2013.11.044","journal-title":"Vaccine"},{"issue":"24","key":"7267_CR60","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","volume":"32","author":"YE Thomassen","year":"2014","unstructured":"Thomassen YE, Rubingh O, Wijffels RH, van der Pol LA, Bakker WAM (2014) Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods. Vaccine 32(24):2782\u20132788. doi: 10.1016\/j.vaccine.2014.02.022","journal-title":"Vaccine"},{"key":"7267_CR61","unstructured":"Van HH, Luitjens A (2011) Method for the production of ad26 adenoviral vectors. WO2011098592 A1,"},{"issue":"1","key":"7267_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00170567","volume":"33","author":"FL Lier van","year":"1990","unstructured":"van Lier FL, van den End EJ, de Gooijer CD, Vlak JM, Tramper J (1990) Continuous production of baculovirus in a cascade of insect-cell reactors. Appl Microbiol Biotechnol 33(1):43\u201347","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"7267_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0168-1656(92)90147-2","volume":"22","author":"FL Lier van","year":"1992","unstructured":"van Lier FL, van der Meijs WC, Grobben NG, Olie RA, Vlak JM, Tramper J (1992) Continuous beta-galactosidase production with a recombinant baculovirus insect-cell system in bioreactors. J Biotechnol 22(3):291\u2013298. doi: 10.1016\/0168-1656(92)90147-2","journal-title":"J Biotechnol"},{"issue":"1","key":"7267_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/bp00025a007","volume":"10","author":"FL Lier van","year":"1994","unstructured":"van Lier FL, van Duijnhoven GC, de Vaan MM, Vlak JM, Tramper J (1994) Continuous beta-galactosidase production in insect cells with a p10 gene based baculovirus vector in a two-stage bioreactor system. Biotechnol Prog 10(1):60\u201364. doi: 10.1021\/bp00025a007","journal-title":"Biotechnol Prog"},{"issue":"6","key":"7267_CR65","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0141-0229(95)00129-8","volume":"18","author":"FLJ Lier van","year":"1996","unstructured":"van Lier FLJ, van den Hombergh JPTW, de Gooijer CD, den Boer MM, Vlak JM, Tramper J (1996) Long-term semi-continuous production of recombinant baculovirus protein in a repeated (fed-)batch two-stage reactor system. Enzyme Microb Tech 18(6):460\u2013466. doi: 10.1016\/0141-0229(95)00129-8","journal-title":"Enzyme Microb Tech"},{"issue":"4","key":"7267_CR66","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/hum.2014.007","volume":"25","author":"J Vellinga","year":"2014","unstructured":"Vellinga J, Smith JP, Lipiec A, Majhen D, Lemckert A, van Ooij M, Ives P, Yallop C, Custers J, Havenga M (2014) Challenges in manufacturing adenoviral vectors for global vaccine product deployment. Hum Gene Ther 25(4):318\u2013327. doi: 10.1089\/Hum.2014.007","journal-title":"Hum Gene Ther"},{"key":"7267_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jbiotec.2015.06.428","volume":"212","author":"A Villiger-Oberbek","year":"2015","unstructured":"Villiger-Oberbek A, Yang Y, Zhou W, Yang J (2015) Development and application of a high-throughput platform for perfusion-based cell culture processes. J Biotechnol 212:21\u201329. doi: 10.1016\/j.jbiotec.2015.06.428","journal-title":"J Biotechnol"},{"key":"7267_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2015.05.010","author":"J Walther","year":"2015","unstructured":"Walther J, Godawat R, Hwang C, Abe Y, Sinclair A, Konstantinov K (2015) The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. J Biotechnol. doi: 10.1016\/j.jbiotec.2015.05.010","journal-title":"J Biotechnol"},{"issue":"12","key":"7267_CR69","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1002\/bit.24584","volume":"109","author":"V Warikoo","year":"2012","unstructured":"Warikoo V, Godawat R, Brower K, Jain S, Cummings D, Simons E, Johnson T, Walther J, Yu M, Wright B, McLarty J, Karey KP, Hwang C, Zhou W, Riske F, Konstantinov K (2012) Integrated continuous production of recombinant therapeutic proteins. Biotechnol Bioeng 109(12):3018\u20133029. doi: 10.1002\/bit.24584","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"7267_CR70","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/bit.260431123","volume":"43","author":"LZ Xie","year":"1994","unstructured":"Xie LZ, Wang DIC (1994) Fed-batch cultivation of animal-cells using different medium design concepts and feeding strategies. Biotechnol Bioeng 43(11):1175\u20131189. doi: 10.1002\/bit.260431123","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"7267_CR71","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/bit.20158","volume":"86","author":"IH Yuk","year":"2004","unstructured":"Yuk IH, Olsen MM, Geyer S, Forestell SP (2004) Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Biotechnol Bioeng 86(6):637\u2013642. doi: 10.1002\/bit.20158","journal-title":"Biotechnol Bioeng"},{"key":"7267_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2015.07.006","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Stobbe P, Silvander CO, Chotteau V (2015) Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor. J Biotechnol. doi: 10.1016\/j.jbiotec.2015.07.006","journal-title":"J Biotechnol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-7267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-015-7267-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-7267-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-7267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:01:24Z","timestamp":1654095684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-015-7267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["7267"],"URL":"https:\/\/doi.org\/10.1007\/s00253-015-7267-9","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]},"assertion":[{"value":"1 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}